Methylprednisolone Completed Phase 2 Trials for Nervous System Diseases / Multiple Sclerosis, Chronic Progressive Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02545959Intrathecal Rituximab in Progressive Multiple Sclerosis